Hopital Bégin
Vincennes, France
Location status: Recruiting
NCT Number: NCT06845865
Multivisceral failure syndrome (MVFS) in humans is associated with a very high risk of mortality, ranging between 30 and 50%. This syndrome is associated with significant systemic inflammation and a high risk of bacteremia, the origin of which is not always identified. Among the possible causes of bacteremia, digestive translocation is the most probable but has not been formally proven to date. This translocation is made possible by the numerous cellular and metabolic alterations secondary to MVFS, which can lead to increased intestinal barrier permeability. Intestinal permeability is currently not systematically evaluated in clinical practice in humans.
This increased intestinal permeability, associated with the presence of inflammatory markers and a septic state, has been studied in several animal models ranging from the fruit fly (Drosophila) to the mouse. These studies have shown a high risk of mortality associated with increased intestinal permeability.
We propose to use this methodology in intensive care patients with at least one organ failure to investigate the link between increased intestinal permeability and survival chances.
Interested in participating?
Request Info18 year and older
All sexes
Observational
Vincennes, France
Location status: Recruiting
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Patient with single organ failure, secondary to sepsis, hospitalized in intensive care for a foreseeable duration of > 48 hours
Second group of patients with multi-organ failure:
Exclusion criteria
Oral administration of 0.5 mg/kg of body weight of food coloring dye
Time frame: 2024-2027
Evaluation of the impact of changes in permeability (classified into 3 categories: absent, moderately increased, and highly increased) on patient survival at day 90
Time frame: 2024-2027
Comparison of average intestinal permeability between patients with a single organ failure versus multiple organ failures on day 1 in the blood (plasma)
Contact information is provided by the study sponsor or research team.
Direction Centrale du Service de Santé des Armées
Other
Acronym: BLUE-REA
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT06749483
Confusion, Critical Illness
Jena, Thuringia, Germany
View Trial DetailsNCT07085624
Bacterial Infections, Bacterial Infections and Mycoses
Grenoble, France
View Trial DetailsNCT06977165
Infection in ICU, Infections
Manchester, Lancashire, United Kingdom
View Trial DetailsNCT06893835
Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications
Cairo, Egypt
View Trial Details